Penicillin G

ADVERTISEMENT

Identification

Molecular formula
C16H18N2O4S
CAS Number
61-33-6
IUPAC Name
(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Molecular Weight
334.39g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3300g/cm3
Synonyms
cephalexin
Interesting facts

Interesting Facts about (6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

This compound is well-known in the realm of medicinal chemistry, particularly as a key player in the development of antibiotics. The structure reveals its complex nature, featuring both thiazolidine rings and a bicyclic framework which contribute to its biological activity. Here are some intriguing facts:

  • Antibiotic Properties: Known for its effectiveness against bacterial infections, this compound belongs to a class of antibiotics that disrupts bacterial cell wall synthesis.
  • Mechanism of Action: The compound functions primarily by inhibiting enzymes involved in the peptidoglycan biosynthesis, an essential component for bacterial cell wall integrity.
  • Synthetic Approaches: Scientists have developed various synthetic methods to create this compound, showcasing its structural complexity and the challenges associated with its synthesis.
  • Pharmacokinetics: Understanding how this compound is metabolized in the body is crucial for optimizing its therapeutic effects and minimizing side effects. Studies into its bioavailability and half-life continue to be a focus in pharmacology.
  • Drug Design: The structure serves as a template for creating semi-synthetic derivatives, enhancing potency and broadening spectrum of activity against resistant strains of bacteria.

As stated by a prominent chemist, "The intricacies of antibiotic design are like solving a puzzle where every piece matters towards the goal of eradicating bacterial infections." This compound exemplifies the intersection of chemistry and medicine, representing both challenges and breakthroughs in the fight against infectious diseases.

ADVERTISEMENT